Accéder au contenu
Merck

Lysosomal processing of progranulin.

Molecular neurodegeneration (2017-08-25)
Xiaolai Zhou, Daniel H Paushter, Tuancheng Feng, Lirong Sun, Thomas Reinheckel, Fenghua Hu
RÉSUMÉ

Mutations resulting in progranulin (PGRN) haploinsufficiency cause frontotemporal lobar degeneration with TDP-43-positive inclusions (FTLD-TDP), a devastating neurodegenerative disease. PGRN is localized to the lysosome and important for proper lysosome function. However, the metabolism of PGRN in the lysosome is still unclear. Here, we report that PGRN is processed into ~10 kDa peptides intracellularly in multiple cell types and tissues and this processing is dependent on lysosomal activities. PGRN endocytosed from the extracellular space is also processed in a similar manner. We further demonstrated that multiple cathepsins are involved in PGRN processing and cathepsin L cleaves PGRN in vitro. Our data support that PGRN is processed in the lysosome through the actions of cathepsins.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Cathepsin D human, recombinant, expressed in HEK 293 cells, ≥95% (SDS-PAGE)